Juvederm Volift Lidocaine 2x 1,0 ml

Juvederm Volift Lidocaine contains 17.5 mg/ml cross-linked hyaluronic acid in a low-swelling Vycross matrix, balanced to pH 7.2 and buffered for skin compatibility. The 0.3 % lidocaine helps keep injections comfortable, even during deeper contouring work.

Compared to traditional 24 mg/ml gels, Vycross combines low- and high-molecular-weight HA for tighter cross-linking, providing firmness and lift with less extrusion force. Independent tests show a 38 % higher elastic modulus compared to Juvederm Ultra 3, meaning it holds shape better and resists shifting under facial movement.

This formulation does not contain mannitol, reducing osmotic swelling. What you inject is close to what you see post-treatment, which is especially important in lips and tear-troughs. Store at 2–25 °C to maintain stability for up to 24 months.

Juvederm Volift Lidocaine is ideal for smoothing deep static wrinkles like grade III–IV nasolabial folds and marionette lines. It also works well to define lips, cheeks, and jaw contours. The elastic Vycross texture allows you to layer small amounts precisely without the puffiness some high-density gels can cause, making it suitable for dynamic areas around the mouth.

Patients range from younger adults looking for subtle lip shaping to older patients needing mid-face support. As with other CE Class III dermal fillers, it should not be used during pregnancy, with active infection, autoimmune disease, or lidocaine allergy.

If adjustments are needed, Volift is fully reversible with hyaluronidase. This ensures safe corrections in delicate zones like the philtrum or perioral area.

Compared to calcium hydroxyapatite or PLLA, Volift delivers immediate volume, minimal downtime, and easy reversibility. Split-face studies confirm it performs as well or better on wrinkle severity over 12 months.

2 x 1 ml Bi-Glass syringes with color-coded plungers and flanges for steady handling

4 x 30 G ½″ thin-wall needles designed to reduce injection force and prevent hub pop-off

Sterile peel pouch and instruction leaflet detailing safety zones, aftercare, and CE certification

Twin traceability labels for patient files and records

Keep syringes upright between 2–25 °C and out of direct sunlight. With correct storage, each batch remains stable for two years.

Clinical studies show wrinkle improvements lasting 12–15 months after a single treatment. About 82 % of patients maintain at least a one-grade improvement at 12 months and 64 % at 15 months. MRI scans even detect remaining HA at 18 months in mid-face areas, confirming long-lasting volume. Lidocaine supports smoother, less traumatic injections, helping maintain filler integrity. For active lifestyles, consider a review at 9 months; for less active patients, 12 months. Touch-ups typically require no more than 0.2 ml per area.

Q1: Is Juvederm Volift CE-marked or FDA-approved?
A1: It is CE-marked for use across Europe but not FDA-cleared in the U.S.

Q2: How long do the results last?
A2: Most patients see improvements for 12–15 months, with some evidence of HA lasting up to 18 months.

Q3: What makes Vycross different?
A3: Vycross blends low- and high-molecular-weight HA for tighter cross-linking, providing lift with less swelling and smoother injections than traditional 24 mg/ml gels.

Allergan Aesthetics, part of AbbVie, manufactures Juvederm in ISO-certified facilities in Pringy, France. The Volift range uses proprietary Vycross technology, protected by over 20 patents. Sustainability goals include 100 % renewable energy at the Pringy site and a syringe recycling program that reclaimed 9 tonnes of plastic in its first year. Allergan Medical Institute provides open-access training and supports research, including long-term studies on Volift’s performance in deep facial folds. In short, Juvederm Volift Lidocaine combines advanced Vycross science and careful French manufacturing to deliver a long-lasting, versatile filler backed by robust clinical data.

Allergan